The Australian Government is now in caretaker period. During this time, updates on this website will be published in accordance with the Guidance on Caretaker Conventions, until after the election.
Members of NHMRC’s Dietary Guidelines Governance Committee (the Governance Committee) have been appointed to consider possible conflicts of interest and potential bias across the revision of the 2013 Australian Dietary Guidelines.
NHMRC has commenced a revision of the 2013 Australian Dietary Guidelines (the 2013 Guidelines) to reflect the best available evidence. NHMRC has established a committee of experts to advise on and develop management strategies for conflicts of interest that may arise during the revision process aligning with the NHMRC Policy on the Disclosure of Interests Requirements for Prospective and Appointed NHMRC Committee Members (2019).
Terms of reference
The Governance Committee has been established under the National Health and Medical Research Council Act 1992, with member appointments made by the Chief Executive Officer (CEO) of NHMRC.
The Governance Committee reports to the CEO of NHMRC through the NHMRC Dietary Guidelines Team and works collaboratively with NHMRC’s Dietary Guidelines Expert Committee (the Expert Committee) and any experts contracted by NHMRC to support the revision process.
The Governance Committee will:
- Review the declared interests of individuals shortlisted by NHMRC to determine any potential, perceived or actual conflict of interest related to the work of the Expert Committee, aligning with the NHMRC Declaration of Interest Policy 2019.
- Assess the declared interests of contractors involved in the Guideline review.
- Advise on management strategies for conflicts of interest on a case by case basis.
- Advise on strategies to manage potential bias related to conflicts of interest in the evidence review.
- Attend Expert Committee meetings determined to be relevant by NHMRC, to provide support and advice in relation to managing conflicts of interest and bias in the evidence.
The term of the Governance Committee commenced on 10 January 2021 and is scheduled to conclude on 10 January 2027.
Advice of the Governance Committee
The Governance Committee advised NHMRC on the process to assess disclosed interests of individuals involved with the revision of the 2013 Guidelines (for example individuals appointed to the Expert Committee and external contractors appointed to conduct evidence evaluations or methodology reviews).
The Governance Committee has provided advice about:
- the types of interests that are relevant to the work of the Expert Committee and external contractors that should be disclosed. This includes a minimum timeframe of five (5) years for which the interest should be declared
- the detail required for each interest, such as the timeframe, source of funding, and theme of activity
- the use of a risk matrix to assess the level of perceived risk associated with different interests
- importance of appointing a chairperson with low risk of perceived or actual conflicts of interest.
The Governance Committee assisted with the development of a Disclosures of Interest form specific to revision of the 2013 Guidelines.
Members
Member information and disclosure of interests
Experts appointed to the Governance Committee represent a wide range of expertise: conflicts of interest management, guideline development and review processes, research methodology, health ethics and stakeholder influence on health research and policy.
Committee members are required to disclose their interests on an ongoing basis. Members are asked to consider perceived interests as well as actual interests. A summary of the interests disclosed by each member on NHMRC Committee Centre as of 12 December 2023 is provided below.
Chair,
Professor
Lisa
Bero
Professor Bero has an interest in the translation of science into clinical practice and health policy, with a particular focus on methods for assessing bias in the design, conduct and dissemination of research. Professor Bero has sat on a number of international committees related to conflicts of interest and research. She has widely published in many journals and her current research program covers bias, meta-analysis and systematic reviews, pharmaceutical policy, tobacco control policy and methods for environmental hazard and risk assessment.
Doctor
Hilda
Bastian
Doctor Bastian has an interest in epidemiology and effectiveness research. She was a founding member and has held multiple roles at the Cochrane Collaboration. She was formerly a senior clinical research scientist at the US National Institutes of Health, in its National Centre for Biotechnology Information. Doctor Bastian headed the Health Information Department at the National Institute of Quality and Efficiency in Health Care in Germany. Her research interest is in factors affecting the validity of systematic reviews.
Professor
Ian
Olver
AM
Professor Olver has been instrumental in establishing multiple oncology clinics across Australia. He has held many leadership positions in the area of oncology and research. In 2020 he accepted the position of Professorial Research Fellow, School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide and Adjunct Professor, School of Public Health, in the Faculty of Health and Medical Sciences. He has published over 330 articles in journals, 28 book chapters and 4 books.
Professor Olver has served on many ethics committees including the Australian Health Ethics Committee of the NHMRC for 9 years and was chair for 6 years until 2018. He also served on the NHMRC Council for 6 years. He serves on the Cancer Monitoring Advisory Group of the Australian Institute of Health and Welfare. He currently chairs the Board for the Sax Institute in Sydney and the Adolescent and Young Adult Advisory Board to Canteen. Professor Olver was awarded Membership of the Order of Australia (AM) in 2011 “for service to medical oncology as a clinician, researcher, administrator and mentor, and to the community through leadership roles with cancer control organisations”.
Associate Professor
Bernadette
Richards
Associate Professor Richards has an interest in the intersection of healthcare, law and ethics. Her research has focussed on consent to treatment, technology and healthcare and organ and tissue donation. She was previously employed at the University of Adelaide Law School for many years and then spent a short period of time researching responsible data governance at the Singapore ETH Centre, Future Health Technologies Project. She serves on two NHMRC Principal Committees and has been involved in public consultations on mitochondrial donation. Her co-authored book, ‘Technology, Healthcare and the Law: An evolving relationship’ was published in early 2022 and she has published over 80 journal articles, book chapters and books.
Adjunct Professor
Davina
Ghersi
(January 2021 to January 2024)
Professor Ghersi was the Senior Principal Research Scientist at NHMRC. She advised on aspects of the evaluation and use of research evidence, including research funded by NHMRC and clinical practice, public health and environmental health guidelines produced by the agency. She is experienced in leading clinical trials, cohort study and guideline reform. Professor Ghersi has published extensively in peer reviewed journals on the topic of best practice methodologies and processes for public health and guideline development.